Article in The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 5 citations in OpenAlex.
Jason F ArnoldJason F. Arnold, J.D., M.P.H., is a fellow at the New York Academy of Medicine and Assistant Director of the Clinical and Translational Research Ethics Program at the Medical University of South Carolina. He serves as Associate Editor (Law and Ethics) of the Journal of Global Health Leadership and as a member of the Clinical Research Ethics Consultation Collaborative, a national network of bioethicists who provide advice on ethical challenges encountered while conducting research. Robert M. Sade, M.D., is Distinguished University Professor, Professor of Cardiothoracic Surgery, Director of the Institute of Human Values in Health Care, and Director of the South Carolina Clinical and Translational Research Institute (Clinical and Translational Science Award) Clinical Research Ethics Core at the Medical University of South Carolina. He currently chairs the Cardiothoracic Ethics Forum and serves as Associate Editor (Ethics) of the Annals of Thoracic Surgery. He is a former chair of the American Association for Thoracic Surgery Ethics Committee, the Society of Thoracic Surgeon's Standards and Ethics Committee, and the American Medical Association's Council on Ethical and Judicial Affairs.
Robert M SadeJason F. Arnold, J.D., M.P.H., is a fellow at the New York Academy of Medicine and Assistant Director of the Clinical and Translational Research Ethics Program at the Medical University of South Carolina. He serves as Associate Editor (Law and Ethics) of the Journal of Global Health Leadership and as a member of the Clinical Research Ethics Consultation Collaborative, a national network of bioethicists who provide advice on ethical challenges encountered while conducting research. Robert M. Sade, M.D., is Distinguished University Professor, Professor of Cardiothoracic Surgery, Director of the Institute of Human Values in Health Care, and Director of the South Carolina Clinical and Translational Research Institute (Clinical and Translational Science Award) Clinical Research Ethics Core at the Medical University of South Carolina. He currently chairs the Cardiothoracic Ethics Forum and serves as Associate Editor (Ethics) of the Annals of Thoracic Surgery. He is a former chair of the American Association for Thoracic Surgery Ethics Committee, the Society of Thoracic Surgeon's Standards and Ethics Committee, and the American Medical Association's Council on Ethical and Judicial Affairs.
Institute of Medical Ethics · GB
Funding
South Carolina Clinical & Translational Research Institute (SCTR)UL1TR001450 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T., FLUME, PATRICK A · 2015 to 2024
$41.1M
NCATS NIH HHS UL1 TR001450
6 · The paper itself
Abstract
Many studies have shown that marijuana can negatively affect the cognitive development of adolescents. For some individuals, marijuana use may also initiate opioid use, dose escalation, and opioid use disorder. States that legalize marijuana should help adolescents through regulation of advertising and availability of marijuana-infused edibles. Such policies may assist in protecting neurodevelopment of the adolescent and young adult brain. The federal government should also remove its prohibition of marijuana sales and use, leaving their regulation to state law-makers.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Regulating Marijuana Use in the United States: Moving Past the Gateway Hypothesis of Drug Use. · full record | OpenQuestion